• insulin
  • Type 2 (non-insulin dependent) diabetes is characterized by insufficient insulin receptors to effect proper glucose control after insulin is released (insulin resistance). (health.am)
  • The patient has increased hunger due to excess insulin release as a result of elevated glucose levels. (health.am)
  • Type 2 diabetics are not ketosis-prone due to the presence of insulin, but do develop a condition of hyperglycemic hyperosmolarity during pregnancy, generally after an episode of vomiting and diarrhea in which the patient replaced fluids with glucose solutions. (health.am)
  • PURPOSE: To report the progress (after 9-year follow-up) of a study designed to determine whether improved glucose control in patients with newly diagnosed non-insulin-dependent diabetes mellitus (NIDDM) is effective in reducing the incidence of clinical complications. (ox.ac.uk)
  • After initial diet therapy, 4209 asymptomatic patients who remained hyperglycemic (fasting plasma glucose levels, 6.0 to 15.0 mmol/L) were assigned to either a conventional therapy policy, primarily with diet alone, or to an intensive therapy policy, aiming for fasting plasma glucose levels of less than 6.0 mmol/L, with assignment to primary therapy with sulfonylurea or insulin (which increased insulin supply) or metformin (which enhanced insulin sensitivity). (ox.ac.uk)
  • RESULTS: All three modes of pharmacologic therapy in the intensively treated group-sulfonylurea, insulin, and metformin-had similar efficacy in reducing the fasting plasma glucose and glycated hemoglobin levels. (ox.ac.uk)
  • Over 9 years, patients assigned to intensive therapy with sulfonylurea or insulin had lower fasting plasma glucose levels (median, 7.3 and 9.0 mmol/L, respectively) than patients assigned to conventional therapy. (ox.ac.uk)
  • In the elderly population, the pancreas do not work properly, thus leading to low insulin production or no insulin production causing diabetes, which is again fuelling the demand of the global self-monitoring blood glucose devices market. (psmarketresearch.com)
  • control
  • Education about glucose control has been shown to have a major impact on the patient's overall health. (health.am)
  • CONCLUSIONS: A report will be published in 1998 after a median duration from randomization of 11 years (range, 6 to 20 years) with an 81% power at a 1% level of significance of detecting whether the obtained improvement in glucose control causes a 15% decrease or increase in the incidence of major complications and whether any specific therapy is advantageous or disadvantageous. (ox.ac.uk)
  • To assess the metabolic control of diabetes mellitus patients registered in a capillary glucose self-monitoring program at home. (scielo.br)
  • The health files were analyzed of patients selected to register the evolution of variables related to capillary glucose self-monitoring at home and metabolic control of diabetes mellitus. (scielo.br)
  • The continuous glucose monitoring results help patients control and alter food intake, exercise, and medications. (psmarketresearch.com)
  • Blood
  • The global self-monitoring blood glucose (SMBG) devices market accounted for $11,171.1 million in 2014, and it is expected to grow with a CAGR of 5.7% during 2015-2022. (psmarketresearch.com)
  • The strips segment in the global self-monitoring blood glucose devices market is witnessing high growth rate, due to increasing cases of diabetes. (psmarketresearch.com)
  • In addition, many tests can be performed using a single glucose meter with different blood glucose strips. (psmarketresearch.com)
  • Also, the increase in healthcare expenditure leads to increase spending on self-monitoring blood glucose devices, resulting in the growth of the market. (psmarketresearch.com)
  • The positive reimbursement of self-monitoring blood glucose devices in major countries including the U.S., the U.K., Germany, France, Italy, Spain, and Japan is the key growth driving factor for its market. (psmarketresearch.com)
  • The technological advancement in the global market of self-monitoring blood glucose is leading to increased acceptances of such devices. (psmarketresearch.com)
  • The restraints associated with the growth of the global market of self-monitoring blood glucose include the product recalls due to either the manufacturing defect or error in results. (psmarketresearch.com)
  • The key companies operating in the global self-monitoring blood glucose devices market include Abbott Laboratories Inc., Medtronic Inc., Hoffmann-La Roche Ltd., Bayer AG , B. Braun Melsungen AG, Nipro Diagnostics Inc., Life Scan Inc.(J&J), Arkray Devices, Nova Biomedical, and Bionime Corporation. (psmarketresearch.com)
  • type
  • With type 2 diabetes, the risk of frank diabetes in a first-degree relative is almost 15%, and about 30% more will have impaired glucose tolerance. (health.am)
  • method
  • This benchmark article described for the first time the theory and procedure of the quantitative autoradiographic [14C] deoxyglucose method for the quantitative determination of local glucose utilization in the nervous system and the values obtained with it in normal and anesthetized rats. (nih.gov)